www.bioss.com.cn
400-901-9800
sales@bioss.com.cn
techsupport@bioss.com.cn
400-901-9800
sales@bioss.com.cn
techsupport@bioss.com.cn
Mouse
Anti-human CD55-PE/Gold
Cat. Number:
bsm-30084M-PE-Gold
Quantity size:
100ul
15nm
Concentration:
0.4mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a protein involved in the regulation of the complement cascade. The encoded glycoprotein is also known as the decay-accelerating factor (DAF); binding of DAF to complement proteins accelerates their decay, disrupting the cascade and preventing damage to host cells. Antigens present on the DAF glycoprotein constitute the Cromer blood group system (CROM). Two alternatively spliced transcripts encoding different proteins have been identified. The predominant transcript encodes a membrane-bound protein expressed on cells exposed to plasma component proteins but an alternatively spliced transcript produces a soluble protein present at much lower levels. Additional, alternatively spliced transcript variants have been described, but their biological validity has not been determined.
Also known as:
CD 55;
CD55;
CD55 antigen;
CD55 Cromer blood group system;
CD55 molecule;
CD55 molecule, decay accelerating factor for complement (Cromer blood group);
Cd55a;
Complement decay accelerating factor;
Complement decay-accelerating factor;
Complement decay-accelerating factor, GPI-anchored;
CR;
CROM;
Cromer Blood Group antigen;
Cromer blood group system;
DAF;
Daf-GPI;
DAF_HUMAN;
Daf1;
Dcay accelerating factor for complement (CD55, Cromer blood group system);
Decay accelarating factor 1, isoform CRA_a;
Decay accelerating factor (GPI-form);
Decay Accelerating Factor for Complement;
Decay accelerating factor GPI-form;
Decay accelerating factor soluble-form;
GPI-DAF;
TC.
Specificity:
●
Mouse Monoclonal IgG, affinity purified by Protein G.
●
Reacts with:
(predicted: )
●
Immunogen: .
●
Predicted Molecular Weight: 35kDa.
Storage:
0.02M TBS(pH8.2) with 1% BSA, 0.03% Proclin300. Store at 2-8 oC for 3-6 months. Avoid repeated freeze/thaw cycles.
Application:
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.